ENGINEERING OF AN ANTIBODY FOR TUMOR-SELECTIVE BINDING OF CD47

Antibodies are provided which comprise at least one Fab portion that binds CD47 and at least one Fab portion that binds the tumor associated antigen (TAA) CD20; wherein the Fab portion that binds CD47 exhibits low affinity for CD47; and, wherein the Fab portion that binds CD20 exhibits high affinity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHO, Ho, JOHNSON, Jeffrey, HADJIVASSILIOU, Haralambos, SUN, Jeonghoon, ZHU, Dan, ACHARYA, Sharmistha, HARIHARAN, Kandasamy
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!